Several studies have demonstrated that the T cells of COVID-19 patients progress from the prodromal stage to the symptomatic stage and exhibit dramatically increased expression of PD-1 and TIM-3 (Diao et al., 2020; Zheng et al., 2020a). The gene discussed is HAVCR2; the disease is COVID-19.